Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Senolytic therapeutics: An emerging treatment modality for osteoarthritis

15 Mar 2024

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to NF-κB Signaling Pathways
Share to Osteoarthritis Treatment and Mechanisms
Share to RNA Interference and Gene Delivery

Source

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Identifiers

PMID: 38494091
DOI: 10.1016/j.arr.2024.102275

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 9 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Senolytic therapeutics: An emerging treatment modality for osteoarthritisPMID 38494091Read ↗

Senolytics and senomorphics: Natural and synthetic therapeutics in the treatment of aging and chronic diseasesSemantic proximity Read ↗

Osteoarthritis update.Semantic proximity Read ↗

Research progress on osteoarthritis treatment mechanismsSemantic proximity Read ↗

Discovery, development, and future application of senolytics: theories and predictions.Semantic proximity Read ↗

Osteoarthritis in 2012: Parallel evolution of OA phenotypes and therapies.Semantic proximity Read ↗

Plant-Derived Senotherapeutics for the Prevention and Treatment of Intervertebral Disc Degeneration and AgingSemantic proximity Read ↗

The role of senolytics in osteoporosis and other skeletal pathologiesSemantic proximity Read ↗

The Development of Disease-Modifying Therapies for Osteoarthritis (DMOADs): The Evidence to Date.Semantic proximity Read ↗

Senolytic Treatment for Low Back PainSemantic proximity Read ↗

Recent advances in the treatment of osteoarthritisSemantic proximity Read ↗

Long-term treatment with senolytic drugs Dasatinib and Quercetin ameliorates age-dependent intervertebral disc degeneration in mice.Semantic proximity Read ↗

Senolytic therapy combining Dasatinib and Quercetin restores the chondrogenic phenotype of human osteoarthritic chondrocytes by promoting the release of pro-anabolic mediatorsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.